203 related articles for article (PubMed ID: 8776961)
1. [Immunohistochemical study of androgen receptor in adenocarcinoma of the human prostatic cancer].
Yoshikawa H; Ikeuchi T; Kai Y
Nihon Hinyokika Gakkai Zasshi; 1996 Jul; 87(7):956-63. PubMed ID: 8776961
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy.
Sadi MV; Walsh PC; Barrack ER
Cancer; 1991 Jun; 67(12):3057-64. PubMed ID: 1710537
[TBL] [Abstract][Full Text] [Related]
3. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy.
Van der Kwast TH; Têtu B; Fradet Y; Dupont A; Gomez J; Cusan L; Diamond P; Labrie F
Prostate; 1996 Apr; 28(4):227-31. PubMed ID: 8602398
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.
Hong H; Kao C; Jeng MH; Eble JN; Koch MO; Gardner TA; Zhang S; Li L; Pan CX; Hu Z; MacLennan GT; Cheng L
Cancer; 2004 Jul; 101(1):83-9. PubMed ID: 15221992
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate.
Chodak GW; Kranc DM; Puy LA; Takeda H; Johnson K; Chang C
J Urol; 1992 Mar; 147(3 Pt 2):798-803. PubMed ID: 1371552
[TBL] [Abstract][Full Text] [Related]
7. Role of androgen receptor in prostatic neoplasia versus hyperplasia.
Husain I; Shukla S; Soni P; Husain N
J Cancer Res Ther; 2016; 12(1):112-6. PubMed ID: 27072221
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue.
Brolin J; Skoog L; Ekman P
Prostate; 1992; 20(4):281-95. PubMed ID: 1376911
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.
Taplin ME; Rajeshkumar B; Halabi S; Werner CP; Woda BA; Picus J; Stadler W; Hayes DF; Kantoff PW; Vogelzang NJ; Small EJ;
J Clin Oncol; 2003 Jul; 21(14):2673-8. PubMed ID: 12860943
[TBL] [Abstract][Full Text] [Related]
10. Tissue prostate-specific antigen and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy.
Ogreid P; Berner A; Dahl O; Rettedal E; Fosså SD
Eur Urol; 1999 Aug; 36(2):116-22. PubMed ID: 10420032
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
12. Transformation of prostatic adenocarcinoma to well-differentiated neuroendocrine tumor after hormonal treatment.
Gilani S; Guo CC; Li-Ning EM; Pettaway C; Troncoso P
Hum Pathol; 2017 Jun; 64():186-190. PubMed ID: 28159676
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
[TBL] [Abstract][Full Text] [Related]
14. Cellular distribution of retinoic acid receptor-alpha in benign hyperplastic and malignant human prostates: comparison with androgen, estrogen and progesterone receptor status.
Gyftopoulos K; Sotiropoulou G; Varakis I; Barbalias GA
Eur Urol; 2000 Sep; 38(3):323-30. PubMed ID: 10940708
[TBL] [Abstract][Full Text] [Related]
15. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
Bonkhoff H; Remberger K
Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptors in endocrine-therapy-resistant human prostate cancer.
van der Kwast TH; Schalken J; Ruizeveld de Winter JA; van Vroonhoven CC; Mulder E; Boersma W; Trapman J
Int J Cancer; 1991 May; 48(2):189-93. PubMed ID: 1708363
[TBL] [Abstract][Full Text] [Related]
17. Establishment of monoclonal antibody to human androgen receptor and its clinical application for prostatic cancers.
Demura T; Kuzumaki N; Oda A; Fujita H; Taniguchi N; Asano Y; Takayama N; Nonomura K; Koyanagi T
Am J Clin Oncol; 1988; 11 Suppl 2():S23-6. PubMed ID: 2468271
[TBL] [Abstract][Full Text] [Related]
18. Correlation between proliferation, apoptosis, and angiogenesis in prostate carcinoma and their relation to androgen ablation.
Matsushima H; Goto T; Hosaka Y; Kitamura T; Kawabe K
Cancer; 1999 Apr; 85(8):1822-7. PubMed ID: 10223578
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review.
Qiu YQ; Leuschner I; Braun PM
Asian J Androl; 2008 Nov; 10(6):855-63. PubMed ID: 18958349
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical changes in prostate cancer after androgen deprivation therapy.
Bostwick DG
Mol Urol; 2000; 4(3):101-6;discussion 107. PubMed ID: 11062363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]